DEPOMED, INC. Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. Trustee INDENTURE Dated as of September 9, 2014 Senior Debt SecuritiesIndenture • September 9th, 2014 • Depomed Inc • Pharmaceutical preparations • New York
DEPOMED, INC. 2.50% CONVERTIBLE SENIOR NOTES DUE 2021 UNDERWRITING AGREEMENTUnderwriting Agreement • September 9th, 2014 • Depomed Inc • Pharmaceutical preparations • New York
DEPOMED, INC. AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A, as Trustee First Supplemental Indenture Dated as of September 9, 2014 to Indenture Dated as of September 9, 2014 2.50% Convertible Senior Notes due 2021First Supplemental Indenture • September 9th, 2014 • Depomed Inc • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE, dated as of September 9, 2014 (this “Supplemental Indenture”), between DEPOMED, INC., a California corporation, as issuer (the “Company,” as more fully set forth in Section 2.01) and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a New York banking association, as trustee (the “Trustee,” as more fully set forth in Section 2.01), supplementing the Indenture relating to “Senior Debt Securities” dated as of September 9, 2014, between the Issuer and the Trustee (the “Base Indenture” and, as amended and supplemented by this Supplemental Indenture, and as it may be further amended or supplemented from time to time with respect to the Notes, the “Indenture”).
